Sorted By:


PhRMA Member Companies Invested $58.8 Billion in R&D in 2015

PhRMA  |  Press Release

As highlighted in the recently released “Medicines in Development for Rare Diseases,” the biopharmaceutical industry is currently developing more than 560 medicines for patients with rare diseases.

Amy Comstock Rick

PhRMA  |  Biography

Rick is called upon frequently by the media and other organizations to speak about biomedical research, and the importance of strong federal funding and policy support.

Julie Flygare, JD

PhRMA  |  Biography

Julie has spoken about narcolepsy to scientific researchers, doctors, nurses, Harvard Medical students, NIH, FDA and CDC government officials and the general public.

Guest Post: Epilepsy Foundation on rare diseases

PhRMA  |  Blog Post

The number of people with epilepsy who don’t have their seizures under control hasn’t changed, despite significant advances in the development of innovative anti-seizure medications, medical devices, and surgical options over the past several years.

Blog: Drugmakers make valid point about insurers' role in high drug costs

Access Better Coverage  |  From Our Network

The American Cancer Society Cancer Action Network recently reported that most health plans in six states that it studied placed all or nearly all of the 22 cancer drugs studied, including some generics, into benefit tiers requiring the biggest out-of-pocket spending by patients.

Welcome to the Catalyst

PhRMA  |  Blog Post

We'll write about our take on the value of the biopharmaceutical sector, as well as how policies and proposals might affect patient access to medicines, medical innovation and the ability of PhRMA member companies to compete here in the U.S. and around the world.

U.S.'s Biopharmaceutical Industry Central to Diverse R&D

PhRMA  |  Video

Tim Garnett, chief medical officer at Eli Lilly and Company underscores that developing innovative, lifesaving medicines for patients is the sole focus of the biopharmaceutical industry.


PhRMA  |  From PhRMA

This balanced approach has driven research on innovative medicines in pediatric patients, resulted in more treatment options for children, and has greatly advanced children’s medical care.

Ask About Adherence: Q&A with Pharmacy Quality Alliance

PhRMA  |  Blog Post

Medical practices are directly impacted as well with alignments of refill requests for all the patient’s chronic meds leading to more efficient patient reviews for the prescriber.–-qa-with-pharmacy-quality-alliance

PhRMA Statement on NAFTA Tribunal Decision in the Eli Lilly Case

PhRMA  |  Press Release

This policy also hurts Canadian patients and the medical community.

New report portrays flourishing pipeline

PhRMA  |  Blog Post

The strong pipeline should be a reminder of how important it is that we maintain a policy and regulatory system that fosters the substantial investments needed to support medical advances.

Roy Herbst

PhRMA  |  Biography

He completed his medical oncology fellowship at Dana Farber Cancer Institute and a medical hematology fellowship at Brigham and Women’s Hospital in Boston, where he additionally received a master’s degree from Harvard University in their clinical investigator training program.

Nearly 200 New Medicines in Development for Diabetes

PhRMA  |  Press Release

The total estimated cost of diagnosed diabetes in the U.S. in 2012 alone was $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity.

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Our industry is committed to working with policymakers to advance solutions that further enhance the private marketplace, lower costs for patients and promote continued medical innovation.

PPA: Spread the word

PhRMA  |  Blog Post

Spread the word on social media like Facebook or Twitter.

Protect Your Health: Important Disaster Preparedness Tips for Harvey and Irma

PhRMA  |  Blog Post

It’s best to bring medical equipment with you, if possible, and stay in touch with emergency responders and/or the closest available health care provider.

EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing

PhRMA  |  Blog Post

The results of the survey confirm that EFPIA and PhRMA member companies have made significant progress in developing processes for clinical trial data access schemes in order to support the shared goal of medical and scientific advancement.

Antibiotics Conference Addresses Lack of New Drugs to Fight Deadly Superbugs

PhRMA  |  Press Release About IDSAThe Infectious Diseases Society of America (IDSA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, patient care, prevention, and public health.

PhRMA Statement on National Governors Association’s Prescription Drug Abuse Reduction Policy Academy

PhRMA  |  Press Release

Find PhRMA Online: Website – facebook – Blog – Twitter – and YouTube – For information on how innovative medicines save lives, visit: For information on the Partnership for Prescription Assistance, visit: For information on ensuring the flow of medicines during public health emergencies, visit

Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans

PhRMA  |  Blog Post

More than twelve disease-modifying medications have been approved by the U.S.

Statement on Global IP Agenda: 2009 Special 301 Report

PhRMA  |  Press Release

China, for instance, continues to circumvent its obligations to protect safety and efficacy data generated by innovative companies and India is no closer to implementing such fundamental protection.

ASCO’s Framework: Value at the Crossroads

PhRMA  |  Blog Post

Read PhRMA's statement on the ASCO Value Framework here.

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

PPA Celebrates 10th Anniversary – This week the Partnership for Prescription Assistance (PPA) celebrated its 10th anniversary of connecting uninsured or underinsured Americans to programs that provide prescription medicines for free or nearly free.

Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world

PhRMA  |  Press Release

The joint statement said the IFPMA, PhRMA, EFPIA, and JPMA are joining forces to help protect patients worldwide by promoting access to safe and efficacious medicines, advocating robust patient education and awareness about counterfeiting, and combating unsafe medicines.

PhRMA Statement on Clinical Trials and Bad Pharma

PhRMA  |  Press Release

Medical innovation would not be possible without the commitment to research and development by the American biopharmaceutical sector.

You have reviewed the first 450 results out of 1046. Each page contains 25 results. You're on page 18.

prev 13 14 15 16 17 18 next